Yahoo Web Search

Search results

  1. Apr 17, 2024 · CareDx, Inc. has appointed John W. Hanna as its new President and Chief Executive Officer, and member of the Company’s Board of Directors, effective April 15, 2024.

  2. Prior to Veracyte, he held leadership positions with IBM’s Global Healthcare and Life Sciences Division, and Humana, Inc.’s Innovation Center, a division for healthcare consumer research. Mr. Hanna began his career in health policy and advocacy at America’s Health Insurance Plans (AHIP) in Washington, D.C.

  3. People also ask

  4. Apr 16, 2024 · Hanna brings to CareDx over two decades of executive leadership at the intersection of new technology development and revenue growth in the molecular diagnostics and life sciences tools...

  5. Apr 16, 2024 · BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solution s for transplant patients – has appointed John W. Hanna as its new President and Chief ...

  6. Chief Executive Officer at Apton Biosystems. Contact. John Hanna's work experience begins in the year 2001 when they started their career at America's Health Insurance Plans (AHIP) as a Non-Profit Operations Manager.

  7. Apr 16, 2024 · John W. Hanna assumed his new role as President and CEO of CareDx on April 15, 2024. What is CareDx known for? CareDx is known as 'The Transplant Company™' and focuses on developing high-value diagnostic solutions for transplant patients.

  8. Apr 16, 2024 · CareDx appointed John Hanna as president, CEO, and member of the company’s Board of Directors, effective April 15. Hanna previously served as CEO of Apton Biosystems, VP of corporate development for Pacific Biosciences, and held several roles at Veracyte, including chief commercial officer and VP of marketing. Prior to Veracyte, Hanna held leadership roles at Humana and IBM.

  1. People also search for